Editorial Comment

Affiliations

Comment

J Stephen Jones. J Urol. 2020 May.

. 2020 May;203(5):938-939.

doi: 10.1097/JU.0000000000000684.01. Epub 2020 Jan 29.

No abstract available

Comment on

Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort.
Weiner AB, Cohen JE, DeLancey JO, Schaeffer EM, Auffenberg GB. Weiner AB, et al. J Urol. 2020 May;203(5):933-939. doi: 10.1097/JU.0000000000000684. Epub 2020 Nov 20. J Urol. 2020. PMID: 31746656 Free PMC article.

Editorial comment.
Zlotta AR. Zlotta AR. J Urol. 2012 May;187(5):1606; discussion 1606-7. doi: 10.1016/j.juro.2011.12.144. Epub 2012 Mar 14. J Urol. 2012. PMID: 22425082 No abstract available.
Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
van der Poel HG. van der Poel HG. Eur Urol. 2009 Jul;56(1):103-4. doi: 10.1016/j.eururo.2009.02.023. Epub 2009 Feb 27. Eur Urol. 2009. PMID: 19282103 No abstract available.
Editorial Comment.
Abdi H, Breau RH. Abdi H, et al. J Urol. 2019 Mar;201(3):518. doi: 10.1097/01.JU.0000553709.74021.24. J Urol. 2019. PMID: 30759693 No abstract available.
Editorial comment to involvement of estrogen receptors in prostatic diseases.
Takahashi S. Takahashi S. Int J Urol. 2012 Jun;19(6):522-3. doi: 10.1111/j.1442-2042.2012.03047.x. Int J Urol. 2012. PMID: 22621219 Review. No abstract available.
[Surgical or medical castration with LH-RH analogue for prostatic cancer].
Kameyama S, Yamazaki S, Kitamura T. Kameyama S, et al. Nihon Rinsho. 1998 Aug;56(8):2114-8. Nihon Rinsho. 1998. PMID: 9750518 Review. Japanese.